ISRG .. $134.85 per share.
See my previous post advising to buy when stock was at $95.00
ARAY could be the next ISRG
(Both deal with "Extremely Advanced Robotics" in Medical Field)
ARAY is a great stock to buy and put away in an account like a 401K or Roth.
NOTE: My motive is simple .... I want to help myself and others to make money so we can be a blessing to others who are in need. As well as our obvious daily lifes.
May God Bless us all who have put our faith in the Lord, Jesus Christ.
best,
Ted :)
Here is some info:
ACCURAY INC COM Company Overview
Accuray Incorporated (Accuray) has developed an intelligent robotic radiosurgery system, the CyberKnife system, designed to treat solid tumors anywhere in the body as an alternative to traditional surgery. The Company's CyberKnife system represents the next generation of radiosurgery systems, combining continuous image-guidance technology with a compact linear accelerator that has the flexibility to move in three dimensions according to the treatment plan (intelligent robotics). The CyberKnife system autonomously tracks, detects and corrects for tumor and patient movement in real time during the procedure, enabling delivery of precise, high-dose radiation typically with sub-millimeter accuracy. In January 2005, Accuray acquired American Science and Engineering's (AS&E) High Energy Systems (HES) business.
Reuters ProVestor Plus Company Report
Shareholder Equity
Shares Outstanding 53.3 M
Institutional Ownership 0.07%
Number of Floating Shares 37.9 M
Short Interest as % of Float 3.04%
Valuation (MRQ)
Price/Earnings (TTM) --
Price/Sales 12.82x
Price/Book --
Price/Cash Flow --
ARAY was not profitable in its latest fiscal year, therefore the P/E Ratio is not applicable. Its Price to Cash Flow Ratio would give an alternative indication of its expense relative to the Medical Equipment & Supplies industry.
Profitability (TTM)
Gross Margin 50.88%
Operating Margin -22.52%
EBITDA Margin -17.32%
Profit Margin -22.43%
ARAY's Gross Margin is comparable to other companies in the Medical Equipment & Supplies industry, which means it has relatively the same amount of cash to spend on business operations as its peers. As indicated by the Operating Margin, ARAY controls its costs and expenses as well as its peers.
Financial Strength (MRQ)
Quick Ratio 0.72x
Current Ratio 0.92x
Debt/Equity --
Debt/Assets 0.00x
Management Effectiveness (TTM)
Return on Assets --
Return on Equity --
Return on Inves. Capital --
Growth Rate (TTM)
Earnings Per Share --
Sales --
Dividend (MRQ) --
Dividend (TTM)
Dividend Yield --
Payout Ratio --
Annual Dividend 0.00
ARAY does not pay a dividend. The average dividend yield for companies in the Medical Equipment & Supplies industry is 0.96%
Operating Ratios (TTM)
Asset Turnover --
Inventory Turnover --
Receivables Turnover --
Effective Tax Rate --
These ratios give an indicator of efficiency (ability to move inventory and generate sales) within a company, particularly ones with tangible goods (i.e. automotive, computer hardware) as compared to its peers.
Company Officers
Chairman Wayne Wu
Director Wayne Wu
Chief Executive Officer Euan S. Thomson
Chief Operating Officer Chris A. Raanes
Chief Financial Officer Robert E. McNamara
President Euan S. Thomson
Company Contact
Employees 0
Headquarters 1310 Chesapeake Terrace
Sunnyvale, CA 94089
Phone 408-716-4600
Fax
Web Address accuray.com |
